Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02456467 · ClinicalTrials.gov registry record

HemoSonics-UVA HemoSonics-UVA Cardiac Surgery Clinical Study Protocol

A clinical trial of Coronary Artery Disease, sponsored by University of Virginia.

Completed
Registry status
50
Enrollment target
1
Study location

NCT02456467: Completed study of Coronary Artery Disease, sponsored by University of Virginia.

NCT02456467 is a study of Coronary Artery Disease that has completed, run by University of Virginia. The registered enrollment target is 50 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02456467, a study of Coronary Artery Disease, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in cardiac surgery patients.

Primary Outcome

Coagulation Function

Conditions Studied

Study Locations (1)

Virginia

  • University of Virginia Health System - Charlottesville

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2015-04
Est. Completion 2015-08
University of Virginia

449 total trials

What the finished NCT02456467 record still lists

NCT02456467 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT02456467 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT02456467 about?

NCT02456467 is a clinical study titled "HemoSonics-UVA HemoSonics-UVA Cardiac Surgery Clinical Study Protocol". This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in cardiac surgery patients.

What is the current status of trial NCT02456467?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2015-04. Estimated completion is 2015-08.

What conditions does trial NCT02456467 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT02456467?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02456467 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02456467's enrollment target sits among peer trials

50 179th of 219 higher than 39 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02456467, the US trial registry maintained by the National Library of Medicine. NCT02456467 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.